×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Moleculin's AML treatment gets EMA's Orphan Drug Designation
The iPSCore™ platform, developed by iXCells Biotechnologies, enables the generation of highly characterized iPSC-derived human cell models
12 Jun 2025
iXCells Biotechnologies USA, Inc. (“iXCells”), a leading cell technology company specializing in
...
Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis, Bringing Total Funding to $17.5M
The BioTech Breakthrough Award has been granted to Asahi Kasei for the Planova™ FG1 Filter
Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research
Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma
Dunbar Pharma Brings First Plant-Derived Dronabinol API to the UK Market Through IPS Pharma
By
Dunbar Pharmaceuticals
Dunbar Pharmaceuticals
18 Aug 2026
Former DePuy Synthes U.S. President Joins Peptilogics Board
By
Peptilogics
Peptilogics
18 Aug 2026
PanTRKare™ Is Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
By
Jiangsu Vcare Pharmatech Co., Ltd.
Jiangsu Vcare Pharmatech Co., Ltd.
17 Aug 2026
Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories
By
Bruker Corporation
Bruker Corporation
11 Aug 2026
Neurolief Advances Veteran Mental Health and Migraine Care With New VA Contract for Prescription Neuromodulation
By
Neurolief Inc.
Neurolief Inc.
11 Aug 2026
Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models
By
Bruker Corporation
Bruker Corporation
10 Aug 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
Qualia NAD+ Shown In Preliminary Clinical Study To Increase NAD+ By 85%
By
Neurohacker Collective
Feb 22
ChromaDex expands its pharmaceutical-grade Niagen® IV and injection offerings to more leading wellness clinics.
By
ChromaDex Corporation
Sep 16
Neurocrine Biosciences Presents New Post-Hoc Data from the KINECT®-HD Study, Demonstrating a Significant Reduction in Disease Burden with INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea
By
Neurocrine Biosciences, Inc.
Jun 30
August
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
